Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 92.28B | 87.77B | 83.12B | 86.08B | 77.32B | 68.91B |
Gross Profit | 21.73B | 20.66B | 18.58B | 15.89B | 13.24B | 12.87B |
EBITDA | 18.83B | 17.85B | 15.86B | 14.22B | 10.51B | 10.56B |
Net Income | 10.78B | 10.18B | 9.25B | 8.20B | 5.32B | 5.38B |
Balance Sheet | ||||||
Total Assets | 130.51B | 125.23B | 120.36B | 105.03B | 103.61B | 97.96B |
Cash, Cash Equivalents and Short-Term Investments | 44.62B | 44.09B | 41.62B | 38.66B | 36.94B | 36.34B |
Total Debt | 169.00M | 921.00M | 675.00M | 552.00M | 440.00M | 638.00M |
Total Liabilities | 37.36B | 34.69B | 35.62B | 33.52B | 35.03B | 29.38B |
Stockholders Equity | 91.16B | 88.58B | 82.98B | 69.88B | 67.03B | 67.11B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 8.53B | 5.34B | 7.41B | 7.51B | 6.67B |
Operating Cash Flow | 0.00 | 13.37B | 8.69B | 9.76B | 9.30B | 8.90B |
Investing Cash Flow | 0.00 | -5.35B | -3.83B | -7.01B | -2.16B | -2.82B |
Financing Cash Flow | 0.00 | -5.62B | -2.24B | -1.24B | -6.79B | -1.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥11.54B | 12.38 | ― | 3.98% | -2.90% | -24.21% | |
75 Outperform | ¥88.68B | 9.81 | ― | 4.85% | 5.02% | -22.36% | |
73 Outperform | ¥13.65B | 10.29 | ― | 3.14% | 2.25% | -26.12% | |
73 Outperform | ¥125.57B | 14.61 | ― | 1.68% | 8.66% | 12.34% | |
66 Neutral | ¥81.99B | 26.40 | ― | 1.18% | 1.89% | 16.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥9.60B | 308.48 | ― | 4.77% | 4.42% | -98.20% |